SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-guided Q3 results and upbeat 2027 EBITDA outlook have driven a sharp share-price rebound. Bulls are discussing potential short covering, while skeptics question whether operating improvements and steel prices can support the outlook given the companys debt.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention amid a sharp neocloud and AI-infrastructure selloff, as concerns about financing costs, debt sustainability and returns on the sectors buildout spill over from CoreWeave credit worries. Traders are divided on the rebound, with some seeing an oversold buying opportunity and others calling it a bull trap that could give way to further declines.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus pancreatic cancer IMPACT trial completed enrollment after expanding from 12 to 48 patients, which traders view as a sign of strong clinical-site and patient interest; the results are still pending. Attention also centers on the FDA-cleared expansion of its recurrent glioblastoma REGAIN trial and anticipated clinical updates, with mostly bullish reactions tempered by uncertainty about what the larger studies will show.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention after a steep selloff, with traders citing upcoming IPO lockup share releases, a reported TD Cowen downgrade, and concerns about valuation, customer concentration and the companys ability to scale. The community is split between expecting more selling and buying the dip, while some attribute the weakness to a broader AI and semiconductor pullback.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are drawing attention for a sharp pullback, with traders repeatedly pointing to insider selling and weak price action; some also cite higher oil prices and broader macro pressure as headwinds. Bulls argue the companys growth and valuation support a recovery, while bears see more downside and question managements approach to shareholder returns.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade to Buy has fueled a rebound conversation after a steep selloff, but traders remain focused on CoreWeaves debt burden, financing costs and ability to turn AI demand and its backlog into cash flow. Bulls call the selloff overdone and welcome the upgrade, while skeptics argue it does not resolve the financing risks and question whether the bounce will hold.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious anniversary post about the companys next chapter fueled speculation about upcoming clinical news or a possible buyout, though some traders dismissed it as a routine message. The debate centers on the still-unconfirmed 80th-event trigger for the Phase 3 REGAL trial: bulls view the prolonged wait as potentially encouraging for patient survival, while skeptics note that the blinded trials timeline alone does not establish efficacy.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

EyePoints wet-AMD Phase 3 setback and trial wind-down have intensified attention on OCULs competing AXPAXLI program. Traders disagree on whether the news reduces competition or raises broader doubts about TKI therapies, while also debating AXPAXLIs prospects ahead of its planned FDA application.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

X-Energys small modular reactor buildout is drawing attention around updates on its Oak Ridge fuel facility and nuclear-grade graphite supply, against a broader AI and data-center power-demand theme. Traders are broadly bullish on the long-term opportunity and Amazons backing, while some remain cautious about execution timelines and the stocks sharp volatility.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Bernsteins upgrade of Datadog to Outperform, citing AI-related growth potential, is driving attention and a share-price rebound. Traders are debating whether the analyst call can sustain the move after recent weakness, with valuation concerns and bearish sentiment still present.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS soon all the fools that sold today will realize that the arbitration news was actually great news.  Not only does it continue the development in China in which SLS will be compensated for (if 3D Doesn’t go bankrupt), it also allows for a clear pathway to a buyout.  I’ve said for months that the potential suitor would want this squashed prior to finalizing any type of deal.  All lines perfect with the quiet period.  Stick to your convictions and reap the rewards.

Sune Frederiksen

5,500% ROI this quarter

Scott

Ample Stocks

Fausto Rossi

Michael Baker

Vincent

GodFamilyFriends

Andy L.

Jay Glenn

Maomaotree K

Rick Glowaki

Sweden

J Shane

OnTheBalance

Kevin N

Joey q

CMSP

Joe Sullivan

Jon brand

Saxon

Duane Nack

F. S. Fetchet

Fortschritt

StockTwits for iOS

 soon all the fools that sold today will realize that the arbitration news was actually great news.  Not only does it continue the development in China in which SLS will be compensated for (if 3D Doesn’t go bankrupt), it also allows for a clear pathway to a buyout.  I’ve said for months that the potential suitor would want this squashed prior to finalizing any type of deal.  All lines perfect with the quiet period.  Stick to your convictions and reap the rewards.

David Maibaum

@Bomber18 3D has $65M on their balance sheet right now from selling rights to Envafolumab...

StockTwits Web

 3D has $65M on their balance sheet right now from selling rights to Envafolumab...

@55X_ROI_Q1_2026 thanks, I actually did not know that.

@Bomber18 it hasn&#39;t even reached average volume today, so not much conviction selling.  Also, OTM puts actually lost value.

 it hasn't even reached average volume today, so not much conviction selling.  Also, OTM puts actually lost value.